|
|
|
Volumn 59, Issue 1, 2006, Pages 20-26
|
|
Predictive factors in esophageal cancer after neoadjuvant therapy;Neoadjuváns terápián átesett nyelocso-rákos betegek prediktív faktorai.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
CD34 ANTIGEN;
MIB 1 ANTIBODY;
MIB-1 ANTIBODY;
MONOCLONAL ANTIBODY;
TUMOR MARKER;
VASCULOTROPIN A;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
CELL PROLIFERATION;
DRUG EFFECT;
ESOPHAGOSCOPY;
ESOPHAGUS TUMOR;
FEMALE;
GENE EXPRESSION REGULATION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
MALE;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTIVARIATE ANALYSIS;
PATHOLOGY;
PREDICTION AND FORECASTING;
RADIATION EXPOSURE;
RISK FACTOR;
SURVIVAL;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIBODIES, ANTINUCLEAR;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD34;
CELL PROLIFERATION;
CHEMOTHERAPY, ADJUVANT;
ESOPHAGEAL NEOPLASMS;
ESOPHAGOSCOPY;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
NEOADJUVANT THERAPY;
PREDICTIVE VALUE OF TESTS;
RADIOTHERAPY, ADJUVANT;
RISK FACTORS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 33745034817
PISSN: 00250295
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
